![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
Applications:
Ingredient(s): Crospovidone
Dosage Form: Tablet
Category: Disintegrants & Superdisintegrants
Technical Specifications: NA
Applications:
Ingredient(s): Crospovidone
Dosage Form: Tablet
Category: Disintegrants & Superdisintegrants
Technical Specifications: NA
Applications:
Ingredient(s): Crospovidone
Dosage Form: Tablet
Category: Disintegrants & Superdisintegrants
Technical Specifications: NA
Applications:
Ingredient(s): Crospovidone
Dosage Form: Tablet
Category: Disintegrants & Superdisintegrants
Technical Specifications: NA
Applications:
Ingredient(s): Polyvinylpyrrolidone
Category: Fillers, Diluents & Binders
Technical Specifications: NA
Applications:
KoVidone® K30 is used as a binder for tablets and capsules.
Ingredient(s): Polyvinylpyrrolidone K30
Category: Fillers, Diluents & Binders
Technical Specifications: NA
Applications:
Ingredient(s): Hydrogen Peroxide Excipient, KoVidone K30
Category: Co-Processed Excipients
Technical Specifications: NA
Applications:
Ingredient(s): Hydrogen Peroxide Excipient, KoVidone K30
Category: Co-Processed Excipients
Technical Specifications: NA